ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Black Book Releases 2025 Survey Findings on Struggling Early-Stage Digital Health Startups at HLTH Europe

Pandemic-Era Boom Fades as Digital Health Founders Warn of Funding Pressures, Operational Overreach, and Growing Demand for Measurable ROI

AMSTERDAM, NL / ACCESS Newswire / June 17, 2025 / Black Book Research today released the findings of a new study presented at HLTH Europe, surveying 54 early-stage digital health startups operating across the European continent. The data highlights significant headwinds facing the sector, including investor pullback, cross-border scalability challenges, and increasing demands from health systems for evidence-based ROI.

According to the study, 62% of early-stage startups are currently relying on bridge or extension rounds to remain operational amid tightening venture capital markets. 41% report they face existential risk if they do not secure additional investment or rapidly demonstrate commercial traction within the next 6-12 months.

"The fundraising bar for Series A has shifted dramatically since 2022," said Doug Brown, Founder of Black Book. "Venture capital firms are demanding later-stage metrics at earlier phases. Without meaningful revenue or real-world impact data, HIT startups are stuck in a precarious holding pattern."

Pandemic-Era Winners Now Facing Burnout

Startups in digital therapeutics and telehealth, two sectors that saw hypergrowth during the COVID-19 pandemic, are now particularly vulnerable. Black Book found that 55% of these companies report unsustainable burn rates, with many struggling to align fixed costs with normalized market demand. Additionally, 48% report difficulty demonstrating clear return on investment (ROI) to health system buyers, a trend contributing to delayed procurement decisions and dropped pilots.

"The urgency that once propelled rapid adoption of virtual care and digital treatments has given way to stricter scrutiny," said Brown "Without robust, data-driven value propositions, vendors are losing relevance in today's outcome-oriented environment."

Distress M&A and Strategic Retrenchment Becoming Commonplace

As revenue plateaus and valuations reset, 39% of surveyed startups say they are actively considering distressed mergers, acquisitions, or internal downsizing. "This mirrors the challenges faced by larger European firms like Doctolib, which despite early momentum, has encountered mounting difficulties balancing growth with profitability."

Unique Challenges for European Digital Health Startups

The report highlights three structural barriers uniquely burdening European digital health ventures:

Fragmented Health Systems: Pan-European scale remains elusive. Varying regulatory standards, reimbursement models, and EHR interoperability frameworks mean digital health companies must localize extensively, inflating go-to-market costs and slowing adoption.

Funding Environment: Since peaking in 2021, health tech funding in Europe has fallen sharply, with growth-stage and late-stage startups most affected. Many institutional investors have redirected capital to biotech, AI infrastructure, or U.S.-based ventures offering faster growth potential.

Demand for ROI and Operational Maturity: European health systems now demand rigorous clinical and economic validation. Startups that overbuilt during the pandemic without a sustainable model are finding themselves deprioritized in vendor evaluations, especially those unable to provide credible cost-saving or outcomes-improving data.

Black Book's findings reflect a market in transition. While digital health remains a priority in long-term healthcare transformation strategies, early-stage companies are calling for better alignment of reimbursement policies, pan-EU regulatory support, and funding mechanisms tailored to the health innovation lifecycle. "The European market doesn't suffer from a lack of ideas," said Brown. "It suffers from systemic frictions that stall even the most promising innovations from reaching scale."

Black Book presented the report in conjunction with HLTH Europe as part of its ongoing independent global research initiatives.

About Black Book Research
Black Book Research is the industry's source for unbiased, crowd-sourced client experience, satisfaction, and loyalty polling across healthcare technology, outsourcing, and managed services sectors. Black Book is not sponsored by vendors, investors, or associations and maintains full independence in its research methodology including HLTH.

Contact:
research@blackbookmarketresearch.com
www.blackbookmarketresearch.com

Contact Information

Press Office
research@blackbookmarketresearch.com
8008637590

.

SOURCE: Black Book Research



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.